Specific labeling of intracellular Toxoplasma gondii with uracil.
about
Disruption of Toxoplasma gondii parasitophorous vacuoles by the mouse p47-resistance GTPases.UNC93B1 mediates host resistance to infection with Toxoplasma gondiiIn vitro and in vivo effects of doxycycline on Toxoplasma gondiiMetabolism and selective toxicity of 6-nitrobenzylthioinosine in Toxoplasma gondiiIn vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin [CP-62,993], and A-56268) on Toxoplasma gondiiGranule-dependent killing of Toxoplasma gondii by CD8+ T cellsActivity of epiroprim (Ro 11-8958), a dihydrofolate reductase inhibitor, alone and in combination with dapsone against Toxoplasma gondiiCharacterization of anti-Toxoplasma activity of SDZ 215-918, a cyclosporin derivative lacking immunosuppressive and peptidyl-prolyl-isomerase-inhibiting activity: possible role of a P glycoprotein in Toxoplasma physiologyInterferon consensus sequence binding protein-deficient mice display impaired resistance to intracellular infection due to a primary defect in interleukin 12 p40 inductionA highly conserved Toxo1 haplotype directs resistance to toxoplasmosis and its associated caspase-1 dependent killing of parasite and host macrophage.Drugs designed to inhibit human p38 mitogen-activated protein kinase activation treat Toxoplasma gondii and Encephalitozoon cuniculi infection.Biochemistry of Plasmodium (malarial parasites).Comparison of mutants of Toxoplasma gondii selected for resistance to azithromycin, spiramycin, or clindamycinLocalization of azithromycin in Toxoplasma gondii-infected cellsTargeted disruption of the GRA2 locus in Toxoplasma gondii decreases acute virulence in mice.Toxoplasma gondii cyclic GMP-dependent kinase: chemotherapeutic targeting of an essential parasite protein kinase.Oxidant-mediated damage of Leishmania donovani promastigotes.In vitro generation of novel pyrimethamine resistance mutations in the Toxoplasma gondii dihydrofolate reductaseCell surface heparan sulfate promotes replication of Toxoplasma gondii.Carbocyclic 6-benzylthioinosine analogues as subversive substrates of Toxoplasma gondii adenosine kinase: biological activities and selective toxicitiesEvaluation of a cyclic GMP-dependent protein kinase inhibitor in treatment of murine toxoplasmosis: gamma interferon is required for efficacy.Ligands of the peripheral benzodiazepine receptor are potent inhibitors of Plasmodium falciparum and Toxoplasma gondii in vitroActivity of the histone deacetylase inhibitor FR235222 on Toxoplasma gondii: inhibition of stage conversion of the parasite cyst form and study of new derivative compoundsHigh-throughput growth assay for Toxoplasma gondii using yellow fluorescent protein.Disruption of the Toxoplasma gondii bradyzoite-specific gene BAG1 decreases in vivo cyst formation.Incorporation of recombinant gamma interferon into liposomes enhances its ability to induce peritoneal macrophage antitoxoplasma activity.Use of Toxoplasma gondii expressing beta-galactosidase for colorimetric assessment of drug activity in vitroIn vitro effects of three new 1,2,4-trioxanes (pentatroxane, thiahexatroxane, and hexatroxanone) on Toxoplasma gondii.Stable DNA transformation in the obligate intracellular parasite Toxoplasma gondii by complementation of tryptophan auxotrophy.Genetic dissection of pyrimidine biosynthesis and salvage in Leishmania donovani.Phytoecdysteroids as modulators of the Toxoplasma gondii growth rate in human and mouse cells.Synthesis, biological evaluation and molecular modeling studies of N6-benzyladenosine analogues as potential anti-toxoplasma agents.CD73-generated adenosine facilitates Toxoplasma gondii differentiation to long-lived tissue cysts in the central nervous system.Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondiiToxoplasma gondii Arginine Methyltransferase 1 (PRMT1) Is Necessary for Centrosome Dynamics during Tachyzoite Cell Division.Stable molecular transformation of Toxoplasma gondii: a selectable dihydrofolate reductase-thymidylate synthase marker based on drug-resistance mutations in malaria.Comparative activity of macrolides against Toxoplasma gondii demonstrating utility of an in vitro microassay.Overexpression of a cytosolic pyrophosphatase (TgPPase) reveals a regulatory role of PP(i) in glycolysis for Toxoplasma gondii.7-Deaza-6-benzylthioinosine analogues as subversive substrate of Toxoplasma gondii adenosine kinase: activities and selective toxicities.Role for endogenous and acquired peroxidase in the toxoplasmacidal activity of murine and human mononuclear phagocytes.
P2860
Q22255523-95618FDA-EC1D-43A4-A6F2-6ECA7065A510Q27313711-769FFF8C-E4F4-4942-A268-B966F500B6C7Q28335472-981E9C79-DE87-419A-B7C1-DB58967F2834Q28343609-F3E0A8C3-E6CA-44CE-935B-885A39D048ABQ28359823-C3EB97A6-68CE-4F98-A8BC-E5C7CCDEE7F2Q28365228-A081FD2C-0776-4A62-894F-90F76EBCCDE0Q28369142-EC90F3CF-7FAC-4CAC-BB22-66E080C1C281Q28379120-89B8B93C-C932-4023-B91E-C0C2F093FE9EQ28513103-4FE4037D-CB5D-49BF-984D-06F3E80F3822Q31156269-77894362-B0CC-424A-9267-80DA858EE398Q33301990-EB2F5AE5-E64B-4592-9F63-08425AF1F24BQ33624148-78A950BF-E71C-4D93-BACA-EAA942A28DAFQ33746997-6D4E012C-B652-4D37-A7F1-33877E1DC1ACQ33755229-E108D7B7-8419-46C7-AC83-3BED3BD8B5F9Q33761427-603E1771-7DFB-4C5F-BBB1-39D1FB0C340EQ33904366-1888FB6C-08D3-43A6-BDC4-33F4CA45D038Q33912662-73C1AB16-D1C6-479E-8EEE-9143494F702AQ33981972-CB714AAE-348B-4506-98DF-B620E8F3C3F2Q34033957-256419EB-297B-46D8-9116-AA45988A9E6CQ34071961-00D720F8-7240-42B9-A1F4-483CCB35A44BQ34105538-7617D59C-33D5-4C92-BEEB-754AB0B79DF9Q34144953-30CDDCCC-3F52-4A1D-9CA6-80A62F6B97DAQ34290022-4A24908E-7680-4143-A448-14BF30307302Q34725225-FF928FE0-D056-44CE-A6E3-FC2BAB603E60Q35029774-EB0237C8-5F58-46CE-87F0-3F4651CF1441Q35088834-92708EBC-6B83-4124-AF07-F9DC0882C4D4Q35137900-091FF7B0-887C-490D-BB44-79F5F444CD6CQ35354962-80BE6EB6-093F-42BC-A610-50B6F4052EE7Q35476035-F7751A2F-BA25-4475-AFD2-96F7744FB316Q35921592-FF418400-C212-4F37-9D90-567BDA9E6620Q35954233-7A933873-02E9-4370-AD55-3FD8313DE964Q36117950-DEA4FAF4-E51E-4D99-B3F8-47BA014DFE54Q36343044-6003DB9B-D7FF-441A-8237-A0CAAA7E4FBFQ36377044-495D92A2-5FC3-4362-8F21-2A6B2DA656BBQ36548253-117CC3A1-27A7-4230-AA2B-3B75168F8432Q36722494-1C1351C0-0B07-44C2-9406-85CA5F942125Q36753766-D307D4E8-E16B-4616-B4EC-E426AE5EFBDCQ36921128-B5244B0A-39FE-46BB-A426-A9DF31F4CC9EQ36969505-864A638F-4541-4B10-97F6-C05EA9BF7061Q36983087-D8577A33-5458-4A6A-8355-6E6FCB741055
P2860
Specific labeling of intracellular Toxoplasma gondii with uracil.
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
1977年论文
@zh
1977年论文
@zh-cn
name
Specific labeling of intracellular Toxoplasma gondii with uracil.
@en
Specific labeling of intracellular Toxoplasma gondii with uracil.
@nl
type
label
Specific labeling of intracellular Toxoplasma gondii with uracil.
@en
Specific labeling of intracellular Toxoplasma gondii with uracil.
@nl
prefLabel
Specific labeling of intracellular Toxoplasma gondii with uracil.
@en
Specific labeling of intracellular Toxoplasma gondii with uracil.
@nl
P1476
Specific labeling of intracellular Toxoplasma gondii with uracil.
@en
P2093
Pfefferkorn ER
Pfefferkorn LC
P2860
P304
P356
10.1111/J.1550-7408.1977.TB04774.X
P577
1977-08-01T00:00:00Z